28 participants
A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-18
- Start Date:
- 2024-06-25
- Completion:
- 2024-09-17
Conditions
- Alzheimer Disease
Interventions
- DRUG
- COMBINATION_PRODUCT
No Results Yet